Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPX-100 in Tibio-Femoral Osteoarthritis of the Knee
NCT06865079Phase 2Active, not recruiting
- Sponsor
- OrthoTrophix, Inc.
- Start
- May 2025
- Primary completion
- Mar 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TPX-100 in osteoarthritis (OA), sponsored by OrthoTrophix, Inc.. Started May 2025; status: active, not recruiting.
02
Drugs
TPX-100
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06865079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06865079.